Depression, assisted reproductive technology/in  vitro fertilization and selective serotonin reuptake inhibitors

In this issue of Fertility and Sterility, Hernandez-Nieto et  al. (1) present reassuring data suggesting that in vitro fertilization (IVF) patients exposed to selective serotonin reuptake inhibitors (SSRIs) in vivo are not susceptible to an increased rate of embryo aneuploidy, and that IVF outcomes of patients exposed to SSRIs do not differ from non-expose d patients (1). This reassuring publication is pertinent for many (5%-50%) of the infertile patients undergoing assisted reproductive technology (ART)/IVF, reporting anxiety and depression, many of them need medications, such as SSRI (1).
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Reflections Source Type: research